A study of the effect of sulphinpyrazone ('Anturan') on blood viscosity.
A double-blind, placebo-controlled crossover study of the effect of sulphinpyrazone on blood viscosity and its determinants (haematocrit, plasma fibrinogen and plasma viscosity) was carried out in 7 healthy male volunteers. Apart from a transient rise in fibrinogen (p less than 0.05) after 3 days of sulphinpyrazone treatment, no significant change in viscosity factors was seen over a 14-day period.
D000328:Adult; D001809:Blood Viscosity / Q000187:drug effects*; D006801:Humans; D008297:Male; D013442:Sulfinpyrazone / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors
D013442:Sulfinpyrazone